Skip to main navigation Skip to search Skip to main content

Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma

  • Dominik Dytfeld
  • , Jagoda Jasielec
  • , Kent A. Griffith
  • , Daniel Lebovic
  • , David H. Vesole
  • , Sundar Jagannath
  • , Ammar Al-Zoubi
  • , Tara Anderson
  • , Kristen Detweiler-Short
  • , Keith Stockerl-Goldstein
  • , Asra Ahmed
  • , Terri Jobkar
  • , Diane E. Durecki
  • , Kathryn McDonnell
  • , Melissa Mietzel
  • , Daniel Couriel
  • , Mark Kaminski
  • , Ravi Vij
  • , Andrzej J. Jakubowiak
  • The University of Chicago
  • University of Michigan, Ann Arbor
  • University of Medical Sciences Poznan
  • Icahn School of Medicine at Mount Sinai
  • Washington University St. Louis

Research output: Contribution to journal › Letter › peer-review

46 Scopus citations
Original languageEnglish
Pages (from-to)e162-e164
JournalHaematologica
Volume99
Issue number9
DOIs
StatePublished - 1 Sep 2014

Keywords

  • Carfilzomib
  • Elderly
  • Lenalidomide
  • Low-dose dexamethasone
  • Multiple myeloma
  • Newly diagnosed

Cite this